The integration profile of EIAV-based vectors

被引:38
作者
Hacker, Caroline V.
Vink, Conrad A.
Wardell, Theresa W.
Lee, Sheena
Treasure, Peter
Kingsman, Susan M.
Mitrophanous, Kyriacos A.
Miskin, James E.
机构
[1] Oxford BioMedica UK Ltd, Medawar Ctr, Oxford OX4 4GA, England
[2] Peter Treasure Stat Serv Ltd, Kings Lynn PE34 3NR, England
关键词
lentiviral vectors; EIAV; gene therapy; integration; safety;
D O I
10.1016/j.ymthe.2006.06.006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lentiviral vectors based on equine infectious anemia virus (EIAV) stably integrate into dividing and nondividing cells such as neurons, conferring long-term expression of their transgene. The integration profile of an EIAV vector was analyzed in dividing HEK293T cells, alongside an HIV-1 vector as a control, and compared to a random dataset generated in silico. A multivariate regression model was generated and the influence of the following parameters on integration site selection determined: (a) within/not within a gene, (b) GC content within 20 kb, (c) within 10 kb of a CpG island, (d) gene density within a 2-Mb window, and (e) chromosome number. The majority of the EIAV integration sites (68%; n = 458) and HIV-1 integration sites (72%; n = 162) were within a gene, and both vectors favored AT-rich regions. Sites within genes were examined using a second model to determine the influence of the gene-specific parameters, gene region, and transcriptional activity. Both EIAV and HIV-1 vectors preferentially integrated within active genes. Unlike the gammaretrovirus MLV, EIAV and HIV-1 vectors do not integrate preferentially into the promoter region or the 5' end of the transcription unit.
引用
收藏
页码:536 / 545
页数:10
相关论文
共 33 条
[1]  
Azzouz M, 2002, J NEUROSCI, V22, P10302
[2]   Long-term replacement of a mutated nonfunctional CNS gene: Reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin [J].
Bienemann, AS ;
Martin-Rendon, E ;
Cosgrave, AS ;
Glover, CPJ ;
Wong, LF ;
Kingsman, SM ;
Mitrophanous, KA ;
Mazarakis, ND ;
Uney, JB .
MOLECULAR THERAPY, 2003, 7 (05) :588-596
[3]   CPG-RICH ISLANDS AND THE FUNCTION OF DNA METHYLATION [J].
BIRD, AP .
NATURE, 1986, 321 (6067) :209-213
[4]   Genome wide analysis of retroviral DNA integration [J].
Bushman, F ;
Lewinski, M ;
Ciuffi, A ;
Barr, S ;
Leipzig, J ;
Hannenhalli, S ;
Hoffmann, C .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (11) :848-858
[5]   Targeting survival: Integration site selection by retroviruses and LTR-retrotransposons [J].
Bushman, FD .
CELL, 2003, 115 (02) :135-138
[6]   Integration site selection by and growth-arrested HIV-Based vectors in dividing IMR-90 lung fibroblasts [J].
Ciuffi, A ;
Mitchell, RS ;
Hoffmann, C ;
Leipzig, J ;
Shinn, P ;
Ecker, JR ;
Bushman, FD .
MOLECULAR THERAPY, 2006, 13 (02) :366-373
[7]   A role for LEDGF/p75 in targeting HIV DNA integration [J].
Ciuffi, A ;
Llano, M ;
Poeschla, E ;
Hoffmann, C ;
Leipzig, J ;
Shinn, P ;
Ecker, JR ;
Bushman, F .
NATURE MEDICINE, 2005, 11 (12) :1287-1289
[8]  
Coffin J. M., 1997, RETROVIRUSES
[9]   Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1 [J].
Crise, B ;
Li, Y ;
Yuan, CC ;
Morcock, DR ;
Whitby, D ;
Munroe, DJ ;
Arthur, LO ;
Wu, XL .
JOURNAL OF VIROLOGY, 2005, 79 (19) :12199-12204
[10]   Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells [J].
De Palma, M ;
Montini, E ;
Santoni de Sio, FR ;
Benedicenti, F ;
Gentile, A ;
Medico, E ;
Naldini, L .
BLOOD, 2005, 105 (06) :2307-2315